Top Markets
#1 TENDIES TENDIES +46.86%
#2 Cash Cat Cash Cat +33.26%
#3 Threshold Network Threshold Network +19.02%
#4 Asteroid Shiba Asteroid Shiba +17.67%
#5 OSK OSK +15.80%
#6 龙虾 (Lobster) 龙虾 (Lobster) +13.42%
#7 Ape and Pepe Ape and Pepe +12.62%
#8 Magma Finance Magma Finance +11.22%
#9 MarsCoin MarsCoin +10.44%
#10 Kite Kite +9.98%
Coin of the day
TENDIES TENDIES
Settings
Language
ENGLISH
Currency
USD
Theme
VISEN Pharmaceuticals VISEN Pharmaceuticals

VISEN Pharmaceuticals

2561
Rank in Stocks #16898
VISEN Pharmaceuticals operates as an investment holding company, concentrating... VISEN Pharmaceuticals operates as an investment holding company, concentrating on the development and commercialization of endocrine treatments across mainland China, Hong Kong, and Taiwan. Their flagship product, Lonapegsomatropin, offers a once-weekly, long-acting growth hormone replacement designed for pediatric growth hormone deficiency. The company is also progressing other therapies, such as TransCon CNP (navepegritide), a long-acting prodrug utilizing c-type natriuretic peptide for achondroplasia, and Palopegteriparatide, a daily parathyroid hormone replacement therapy intended for chronic hypoparathyroidism. VISEN has forged strategic collaborations with Shanghai Pharmaceutical and United Family Healthcare. The enterprise was founded in 2018 and is based in Suzhou, China.
Share Price
$2.46
Market Cap
$268.65M
Change (1 day)
-1.73%
Change (1 year)
-57.06%
Country
CN
Trade VISEN Pharmaceuticals (2561)

Category

Healthcare
Earnings for VISEN Pharmaceuticals (2561)
Earnings in 2026 TTM: 0
According to VISEN Pharmaceuticals latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for VISEN Pharmaceuticals from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
- -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
- -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
- -
JP
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
$1.76B -
IN
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
- -
CH